Manipal Health Enterprises Limited (NSE:MANIPALHOS)
India · Delayed Price · Currency is INR 702.20
+15.85 (2.31%)
Aug 11, 2026, 3:29 PM IST
NSE:MANIPALHOS Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 103,358 | 82,423 | 61,716 | 48,396 | 39,752 | |
Revenue Growth | 25.40% | 33.55% | 27.52% | 21.74% | - |
Cost of Revenue | 39,194 | 31,478 | 22,718 | 18,192 | 15,443 |
Gross Profit | 64,163 | 50,945 | 38,998 | 30,204 | 24,309 |
Selling, General & Admin | 4,601 | 3,861 | 2,840 | 2,027 | 285.5 |
Other Operating Expenses | 32,674 | 24,641 | 18,963 | 15,234 | 14,854 |
Operating Expenses | 44,854 | 34,759 | 26,149 | 20,758 | 17,699 |
Operating Income | 19,309 | 16,185 | 12,849 | 9,446 | 6,610 |
Interest Expense | -8,219 | -4,756 | -4,032 | -3,081 | -2,892 |
Interest & Investment Income | 616.31 | 190.62 | 105.91 | 173.5 | 71.7 |
Earnings From Equity Investments | - | - | - | -291.09 | -215.2 |
Currency Exchange Gain (Loss) | -26.32 | -9.82 | -4.77 | -2.06 | -5.3 |
Other Non Operating Income (Expenses) | 268.93 | 339.14 | 42.3 | -204.11 | -191.5 |
EBT Excluding Unusual Items | 11,949 | 11,949 | 8,961 | 6,042 | 3,378 |
Impairment of Goodwill | - | - | -1,141 | - | - |
Gain (Loss) on Sale of Investments | 544.99 | 338.39 | 260.91 | 642.81 | 893.3 |
Gain (Loss) on Sale of Assets | 12.64 | -4.18 | 23.71 | 7.53 | 0.1 |
Other Unusual Items | -726.66 | 139.53 | -654.25 | -984.57 | 2,100 |
Pretax Income | 11,780 | 12,423 | 7,450 | 5,707 | 6,372 |
Income Tax Expense | 2,615 | 1,606 | 2,118 | 1,565 | 904.6 |
Earnings From Continuing Operations | 9,165 | 10,817 | 5,332 | 4,142 | 5,467 |
Earnings From Discontinued Operations | - | - | - | - | -49.8 |
Net Income to Company | 9,165 | 10,817 | 5,332 | 4,142 | 5,417 |
Minority Interest in Earnings | -242 | -163.1 | 611.18 | 80.42 | 1.6 |
Net Income | 8,923 | 10,654 | 5,943 | 4,222 | 5,419 |
Net Income to Common | 8,923 | 10,654 | 5,943 | 4,222 | 5,419 |
Net Income Growth | -16.24% | 79.26% | 40.75% | -22.08% | - |
Shares Outstanding (Basic) | 1,157 | 1,152 | 1,128 | 1,117 | 1,117 |
Shares Outstanding (Diluted) | 1,163 | 1,152 | 1,132 | 1,124 | 1,118 |
Shares Change | 0.98% | 1.80% | 0.72% | 0.50% | - |
EPS (Basic) | 7.71 | 9.25 | 5.27 | 3.78 | 4.85 |
EPS (Diluted) | 7.67 | 9.25 | 5.25 | 3.76 | 4.85 |
EPS Growth | -17.05% | 76.13% | 39.63% | -22.41% | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 7,622 | 5,155 | 10,567 | 8,224 | 6,287 |
Free Cash Flow Per Share | 6.55 | 4.47 | 9.34 | 7.32 | 5.62 |
Gross Margin | 62.08% | 61.81% | 63.19% | 62.41% | 61.15% |
Operating Margin | 18.68% | 19.64% | 20.82% | 19.52% | 16.63% |
Profit Margin | 8.63% | 12.93% | 9.63% | 8.72% | 13.63% |
Free Cash Flow Margin | 7.38% | 6.25% | 17.12% | 16.99% | 15.82% |
EBITDA | 24,423 | 20,043 | 15,916 | 11,911 | 8,588 |
EBITDA Margin | 23.63% | 24.32% | 25.79% | 24.61% | 21.61% |
D&A For EBITDA | 5,114 | 3,858 | 3,067 | 2,465 | 1,978 |
EBIT | 19,309 | 16,185 | 12,849 | 9,446 | 6,610 |
EBIT Margin | 18.68% | 19.64% | 20.82% | 19.52% | 16.63% |
Effective Tax Rate | 22.20% | 12.93% | 28.43% | 27.43% | 14.20% |
Revenue as Reported | 105,205 | 83,628 | 62,652 | 49,276 | 40,844 |
Advertising Expenses | 3,703 | 3,176 | 2,361 | 1,635 | - |